PRECISIONBIOLOGICS
Menu
↗
PRECISION BIOLOGICS / LOCATIONS

Pain Medicine Biologics Supplier in Durham, North Carolina

Precision Biologics supplies Wharton's jelly tissue products and cord-derived exosome products to licensed pain management and physical medicine practices in Durham, North Carolina. Accounts are verified by NPI before any shipment goes out, and we do not provide guidance on indications, dosing, or protocols. We handle sourcing, lot documentation, and a logistics process built for practices that already carry other cold-chain or specialty inventory.

How pain and physical medicine groups in Durham structure vendor review

Pain medicine and physical medicine practices frequently share a medical director across several treating providers, so a new supplier is usually reviewed once at the group level rather than physician by physician. That review tends to focus on documentation, certificate of analysis, donor eligibility summary, lot release record, and on whether registration and licensure records can be produced, rather than on marketing claims about any product.

  • Certificate of analysis for the specific lot
  • Donor eligibility summary
  • Lot release record
  • Registration and licensure documentation on request
REGISTRY DATA / NC

Durham

NPPES registry listings, primary taxonomy, retrieved 2026-10-27

66
Pain Medicine
26
Physical Medicine & Rehabilitation
40
Source: NPPES NPI Registry ↗

Shipping into the Southeast and internal intake

Cryopreserved Wharton's jelly formats ship overnight on dry ice and require immediate transfer to -80 degree C storage on arrival; lyophilized exosome products are shelf-stable and do not need that step. A multi-room practice benefits from deciding in advance who receives shipments and how the lot number gets attached to the eventual patient record, since that link is what traceability depends on.

Exosome products and regulatory posture

FDA has stated there are no FDA-approved exosome products, and these products are generally regulated as biologic drugs rather than under the 361 HCT/P framework that applies to some Wharton's jelly products. A Durham practice adding an exosome product to its supply chain should confirm its own regulatory position with the North Carolina medical board and its counsel rather than relying on anything a supplier publishes.

FDA has stated there are no FDA-approved exosome products. Exosome products are generally regulated as biologic drugs under section 351 of the Public Health Service Act, not as 361 HCT/Ps. Purchase and clinical use decisions belong to the physician with their own regulatory counsel.

These products are not FDA approved or licensed for any disease or condition. Information is for licensed healthcare professionals and is not medical or legal advice.

FAQ

Frequently asked questions

Can one account cover multiple providers at a Durham pain practice?+

Yes. Once the practice's NPI is verified, a medical director or office manager can manage documentation requests for the group.

Is Bio Xsomes approved by the FDA?+

No. FDA has stated there are no FDA-approved exosome products; purchase and use decisions remain with the physician and their regulatory counsel.

What's the difference in how Bio PRP Jelly and Bio DPM ship to Durham?+

Bio PRP Jelly is cryopreserved and ships overnight on dry ice for -80 degree C storage; Bio DPM is lyophilized and shelf-stable without cryogenic storage.